1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Cf102: new trials by email Literature Review of Cf102 trials Research Report on Cf102
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis Namodenoson, Placebo - Hepatocellular Carcinoma, Cirrhosis | Phase 3 | Recruiting | Can-Fite BioPharma | 471 | 2023-03-15 | 2025-04-29 |
Carcinoma, Hepatocellular (1) · Fibrosis (1) · Liver Neoplasms (1)
Bosnia and Herzegovina (1) · Bulgaria (1) · Israel (1) · Moldova (1) · Poland (1) · Romania (1) · Serbia (1) · Slovakia (1) · United States (1)